Familial risk in head and neck squamous cell carcinoma diagnosed before the age of 45: A population-based study

Oral Oncology

Volumn 35, Issue 4, 1999, Pages 360-367

  Mork, Jon ^a,b   Møller, Bjørn ^a   Glattre, Eystein ^a  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Age of onset; Cancer risk; Family; Head and neck; Sex

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILIAL INCIDENCE; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGE OF ONSET; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHILD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; NORWAY; PEDIGREE; RISK FACTORS;

EID: 0033168772     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00069-4     Document Type: Article

References (34)

1. Brugere J., Guenel P., Leclerc A., Rodriguez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer. 57:1986;391-395.
2. Blot W.J., McLaughlin J.K., Winn D.M.et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Research. 48:1988;3282-3287.
3. Copper M.P., Jovanovic A., Nauta J.J.et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Archives of Otolaryngology, Head and Neck Surgery. 121:1995;157-160.
4. Foulkes W.D., Brunet J.S., Sieh W., Black M.J., Shenouda G., Narod S.A. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. British Medical Journal. 313:1996;716-721.
5. Foulkes W.D., Brunet J.S., Kowalski L.P., Narod S.A., Franco E.L. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. International Journal of Cancer. 63:1995;769-773.
6. Goldstein A.M., Blot W.J., Greenberg R.S.et al. Familial risk in oral and pharyngeal cancer. European Journal of Cancer, Oral Oncology. 30B:1994;319-322.
7. Lynch H.T., Fusaro R.M., Lynch J. Hereditary cancer in adults. Cancer Detection and Prevention. 19:1995;219-233.
8. Goldgar D.E., Easton D.F., Cannon Albright L.A., Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. Journal of the National Cancer Institute. 86:1994;1600-1608.
9. Harvard report on cancer prevention.Causes of human cancer.Genetic susceptibility.Cancer Causes Control 1996; 7 (Suppl.1): S23-S24.
10. Begg C.B., Zhang Z.F., Sun M., Herr H.W., Schantz S.P. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. American Journal of Epidemiology. 142:1995;653-665.
11. Schou G., Storm H.H., Jensen O.M. Second cancer following cancers of the buccal cavity and pharynx in Denmark, 1943-80. National Cancer Institute Monographs. 68:1985;253-276.
12. Mork J., Thoresen S., Faye Lund H., Langmark F., Glattre E. Head and neck cancer in Norway.A study of the quality of the Cancer Registry of Norway's data on head and neck cancer for the period 1953-1991. Acta Pathologica, Microbiogica et Immunologica Scandinavica. 103:1995;375-382.
13. International Classification of Diseases, Seventh Revision.WHO, Geneva, Switzerland 1955.
14. Breslow N.E., Day N.E.Statistical Methods in Cancer Research, Vol.II, The Design and Analysis of Cohort Studies.IARC, Lyon, 1987.
15. Breslow N.E., Day N.E.Statistical Methods in Cancer Research, Vol.I, The Analysis of Case-Control Studies.IARC, Lyon, 1980.
16. Preston D.L., Lubin J.H., Pierce D.A., McConney M.E.Epicure.User's guide.Hirosoft International Corporation, Seattle, 1993.
17. Knudson A.G.In: Burchenal J.H., Oettgen H.F., editors.Cancer.Achievements, Challanges and Prospects for the 1980s, Vol.1.Grune & Stratton, New York, 1981, p.386.
18. Spitz M.R., Fueger J.J., Beddingfield N.A.et al. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Research. 49:1989;4626-4628.
19. Cloos J., Spitz M.R., Schantz S.P.et al. Genetic susceptibility to head and neck squamous cell carcinoma. Journal of the National Cancer Institute. 88:1996;530-535.
20. Spitz M.R., McPherson R.S., Jiang H.et al. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiology Biomarkers and Prevention. 6:1997;687-692.
21. Bondy M.L., Spitz M.R., Halabi S.et al. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiology Biomarkers and Prevention. 2:1993;103-106.
22. Park J.Y., Muscat J.E., Ren Q.et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiology Biomarkers and Prevention. 6:1997;791-797.
23. Trizna Z., Clayman G.L., Spitz M.R., Briggs K.L., Goepfert H. Glutathione S-transferase genotypes as risk factors for head and neck cancer. American Journal of Surgery. 170:1995;499-501.
24. Lafuente A., Pujol F., Carretero P., Villa J.P., Cuchi A. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Letters. 68:1993;49-54.
25. Deakin M., Elder J., Hendrickse C.et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 17:1996;881-884.
26. Ryberg D., Hewer A., Phillips D.H., Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Research. 54:1994;5801-5803.
27. Kure E.H., Ryberg D., Hewer A.et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 17:1996;2201-2205.
28. Zang E.A., Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. Journal of the National Cancer Institute. 88:1996;183-192.
29. Muscat J.E., Richie Jr J.P., Thompson S., Wynder E.L. Gender differences in smoking and risk for oral cancer. Cancer Research. 56:1996;5192-5197.
30. Loury M.C., Johns M.E., Danes B.S. In vitro hyperdiploidy in head and neck cancer.A genetic predisposition? Archives of Otolaryngology, Head and Neck Surgery. 113:1987;1230-1233.
31. Liu H., Wormke M., Safe S.H., Bjeldanes L.F. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. Journal of the National Cancer Institute. 86:1994;1758-1765.
32. Birkeland S.A., Storm H.H., Lamm L.U.et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. International Journal of Cancer. 60:1995;183-189.
33. Franceschi S., Levi F., Lucchini F., Negri E., Boyle P., La Vecchia C. Trends in cancer mortality in young adults in Europe, 1955-1989. European Journal of Cancer. 30A:1994;2096-2118.
34. Schantz S.P., Byers R.M., Goepfert H., Shallenberger R.C., Beddingfield N. The implication of tobacco use in the young adult with head and neck cancer. Cancer. 62:1988;1374-1380.